AKT1 and Insulin resistance: In our prior study of HFD-induced obese mice, systemic delivery of Mir181b mimics (to overexpress Mir181b) improved insulin resistance and increased phospho-AKT in eWAT but not in liver or skeletal muscle (Sun et al., 2016).